✦ LIBER ✦

Recent advancements in the treatment of melanoma: Part II---At long last, help for patients with metastatic melanoma

✍ Scribed by Grant-Kels, Jane M.

Book ID: 123582683
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 78 KB
Volume: 31
Category: Article
ISSN: 0738-081X
DOI: 10.1016/j.clindermatol.2012.08.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

How recent advances in immunotherapy are

How recent advances in immunotherapy are changing the standard of care for patients with metastatic melanoma

✍ Wolchok, J. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 318 KB

Phase II Trial (BREAK-2) of the BRAF Inh

Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma

✍ Ascierto, P. A.; Minor, D.; Ribas, A.; Lebbe, C.; O'Hagan, A.; Arya, N.; Guckert 📂 Article 📅 2013 🏛 American Society of Clinical Oncology 🌐 English ⚖ 182 KB

Recombinant interferon α-2a in combinati

Recombinant interferon α-2a in combination with dacarbazine in the treatment of metastatic malignant melanoma: analysis of long-term responding patients

✍ Ilan G. Ron; Moshe J. Inbar; Mordechai Gutman; Ofer Merimsky; Samario Chaitchik 📂 Article 📅 1993 🏛 Springer-Verlag 🌐 English ⚖ 987 KB

Phase II trial of recombinant human inte

Phase II trial of recombinant human interleukin-2 and interferon-alpha-2a: Implications for the treatment of patients with metastatic melanoma

✍ Omar Eton; Moshe Talpaz; Kyoo H. Lee; Jeanne M. Rothberg; Joanna M. Brell; Rober 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 664 KB

Is there a role for targeting vascular e

Is there a role for targeting vascular endothelial growth factor/receptor axis in the treatment of patients with metastatic melanoma?

✍ Kevin B. Kim 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

Chemoimmunotherapy with dacarbazine, cis

Chemoimmunotherapy with dacarbazine, cisplatin, interferon-alpha2b and interleukin-2 versus two cycles of dacarbazine followed by chemoimmunotherapy in patients with metastatic melanoma: A randomised phase II study of the European Organization for Research and Treatment of Cancer Melanoma Group

✍ C.J.A. Punt; S. Suciu; M.A. Gore; J. Koller; W.H.J. Kruit; J. Thomas; P. Patel; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 150 KB